Literature DB >> 33672238

Differential Effects of STCH and Stress-Inducible Hsp70 on the Stability and Maturation of NKCC2.

Dalal Bakhos-Douaihy1,2, Elie Seaayfan1,2, Sylvie Demaretz1,2, Martin Komhoff3, Kamel Laghmani1,2.   

Abstract

Mutations in the Na-K-2Cl co-transporter NKCC2 lead to type I Bartter syndrome, a life-threatening kidney disease. We previously showed that export from the ER constitutes the limiting step in NKCC2 maturation and cell surface expression. Yet, the molecular mechanisms involved in this process remain obscure. Here, we report the identification of chaperone stress 70 protein (STCH) and the stress-inducible heat shock protein 70 (Hsp70), as two novel binding partners of the ER-resident form of NKCC2. STCH knock-down increased total NKCC2 expression whereas Hsp70 knock-down or its inhibition by YM-01 had the opposite effect. Accordingly, overexpressing of STCH and Hsp70 exerted opposite actions on total protein abundance of NKCC2 and its folding mutants. Cycloheximide chase assay showed that in cells over-expressing STCH, NKCC2 stability and maturation are heavily impaired. In contrast to STCH, Hsp70 co-expression increased NKCC2 maturation. Interestingly, treatment by protein degradation inhibitors revealed that in addition to the proteasome, the ER associated degradation (ERAD) of NKCC2 mediated by STCH, involves also the ER-to-lysosome-associated degradation pathway. In summary, our data are consistent with STCH and Hsp70 having differential and antagonistic effects with regard to NKCC2 biogenesis. These findings may have an impact on our understanding and potential treatment of diseases related to aberrant NKCC2 trafficking and expression.

Entities:  

Keywords:  Bartter syndrome; ERAD; Hsp70; NKCC2; STCH; hypertension; membrane; trafficking

Mesh:

Substances:

Year:  2021        PMID: 33672238      PMCID: PMC7926544          DOI: 10.3390/ijms22042207

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  73 in total

1.  The endoplasmic reticulum-gateway of the secretory pathway

Authors: 
Journal:  Plant Cell       Date:  1999-04       Impact factor: 11.277

2.  Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome.

Authors:  R Vargas-Poussou; D Feldmann; M Vollmer; M Konrad; L Kelly; L P van den Heuvel; L Tebourbi; M Brandis; L Karolyi; S C Hebert; H H Lemmink; G Deschênes; F Hildebrandt; H W Seyberth; L M Guay-Woodford; N V Knoers; C Antignac
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

3.  Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination.

Authors:  O Staub; I Gautschi; T Ishikawa; K Breitschopf; A Ciechanover; L Schild; D Rotin
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

4.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

5.  Multiple evolutionarily conserved Di-leucine like motifs in the carboxyl terminus control the anterograde trafficking of NKCC2.

Authors:  Nancy Zaarour; Sylvie Demaretz; Nadia Defontaine; Yingying Zhu; Kamel Laghmani
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

6.  Secretory carrier membrane protein 2 regulates exocytic insertion of NKCC2 into the cell membrane.

Authors:  Nancy Zaarour; Nadia Defontaine; Sylvie Demaretz; Anie Azroyan; Lydie Cheval; Kamel Laghmani
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

7.  Bacterial contig map of the 21q11 region associated with Alzheimer's disease and abnormal myelopoiesis in Down syndrome.

Authors:  J Groet; J H Ives; A P South; P R Baptista; T A Jones; M L Yaspo; H Lehrach; M C Potier; C Van Broeckhoven; D Nizetić
Journal:  Genome Res       Date:  1998-04       Impact factor: 9.043

Review 8.  Molecular regulation of NKCC2 in the thick ascending limb.

Authors:  Gustavo R Ares; Paulo S Caceres; Pablo A Ortiz
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-07

9.  Endoplasmic reticulum (ER) mannosidase I is compartmentalized and required for N-glycan trimming to Man5-6GlcNAc2 in glycoprotein ER-associated degradation.

Authors:  Edward Avezov; Zehavit Frenkel; Marcelo Ehrlich; Annette Herscovics; Gerardo Z Lederkremer
Journal:  Mol Biol Cell       Date:  2007-11-14       Impact factor: 4.138

10.  Allosteric heat shock protein 70 inhibitors rapidly rescue synaptic plasticity deficits by reducing aberrant tau.

Authors:  Jose Abisambra; Umesh K Jinwal; Yoshinari Miyata; Justin Rogers; Laura Blair; Xiaokai Li; Sandlin P Seguin; Li Wang; Ying Jin; Justin Bacon; Sarah Brady; Matthew Cockman; Chantal Guidi; Juan Zhang; John Koren; Zapporah T Young; Christopher A Atkins; Bo Zhang; Lisa Y Lawson; Edwin J Weeber; Jeffrey L Brodsky; Jason E Gestwicki; Chad A Dickey
Journal:  Biol Psychiatry       Date:  2013-04-19       Impact factor: 13.382

View more
  2 in total

1.  Golgi Alpha1,2-Mannosidase IA Promotes Efficient Endoplasmic Reticulum-Associated Degradation of NKCC2.

Authors:  Sylvie Demaretz; Elie Seaayfan; Dalal Bakhos-Douaihy; Nadia Frachon; Martin Kömhoff; Kamel Laghmani
Journal:  Cells       Date:  2021-12-29       Impact factor: 6.600

Review 2.  Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians.

Authors:  Laura Nuñez-Gonzalez; Noa Carrera; Miguel A Garcia-Gonzalez
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.